sec filing

NASDAQ · BCAB
BioAtla, Inc.
Healthcare · Biotechnology
$1.74
Up+$0.42 (+31.44%)
Updated Oct 6, 2026, 9:30 PM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 46.1M
- P/E ratio
- -0.94
- Dividend yield
- 0.00%
- 52-week range
- $0.15 – $8.20
- Volume
- 1.03M
- Avg. volume
- 1.41M
Price performance · BCAB
BCAB price history
1M range · 0 trading sessions · Daily adjusted prices
BCAB does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest BCAB news
The latest Smart Investors Daily articles mentioning BCAB.
Stock researchResearch & News · Analysis
Company
Market Activity
Research & News
Loading stock research…

